secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001193125-23-066281
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva issues €1.3B and $1.1B senior notes at 7.375%-8.125% to fund $2.5B tender offer
--------------------------------------------------------------------------------

- Issued €800M 7.375% '29 notes and €500M 7.875% '31 notes; plus $600M 7.875% '29 and $500M 8.125% '31 notes.
- Net proceeds to fund tender offer for up to $2.5B (upsized from $2.25B) and repay outstanding debt.
- Interest increases 0.10% per sustainability target not met starting Sep 2026.
- Notes are senior unsecured, guaranteed by Teva; redeemable at make-whole or par near maturity.
- Issuers: Teva Finance II (Euro) and Teva Finance III (USD).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312523066281/0001193125-23-066281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312523066281/d475718d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-066281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer